|
|
This is only a preview of the paper
Click here to register and get the full text.
Existing members click here to login
|
|
|
... Secondly, veterinarians generally prefer offering cheaper options to their clients, and Biopure would need their support in order to successfully market this product. ... The human market might deduce that Hemopure would work for humans since it is also produced by Biopure, through similar processes. The immediate release of Oxyglobin might also positively affect an IPO because Biopure is currently not a publicly traded corporation. If proven effective in the marketplace, Oxyglobin can help to create positive brand equity and image for Biopure. ... This would leave Biopure with a 68% gross margin equaling $118. ... This would be the first profit realized by Biopure (see table 3). ... If this proposal is a success, Biopure will recognize its first ever profit.
Approximate Word count = 1181
Approximate Pages = 4.7
(250 words per page double spaced)
|
|
|
|
|
|